Exploring the effect of vitamin D3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis

Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients

(2016) S. Wergeland et al.   EUROPEAN JOURNAL OF NEUROLOGY

Illuminating vitamin D effects on B cells - the multiple sclerosis perspective

(2016) Linda Rolf et al.   IMMUNOLOGY

Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study

(2016) Anne-Hilde Muris et al.   JOURNAL OF NEUROIMMUNOLOGY

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein–Barr virus in relapsing-remitting multiple sclerosis

(2016) Egil Røsjø et al.   Multiple Sclerosis Journal

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein–Barr virus in relapsing-remitting multiple sclerosis

(2016) Egil Røsjø et al.   Multiple Sclerosis Journal

Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis

(2015) Elias S. Sotirchos et al.   NEUROLOGY

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT

(2015) Kassandra L. Munger et al.   NEUROLOGY

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis

(2014) Silje Kvistad et al.   Multiple Sclerosis Journal

Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression

(2014) Alberto Ascherio et al.   JAMA Neurology

Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort

(2013) Caren Ramien et al.   Multiple Sclerosis Journal

Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients

(2013) Giulio Disanto et al.   Multiple Sclerosis Journal

Understanding the joint effects of EBV and vitamin D in MS

(2013) Kassandra Munger et al.   Multiple Sclerosis Journal

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

(2012) Ellen M. Mowry et al.   ANNALS OF NEUROLOGY

Low vitamin D and elevated immunoreactivity against Epstein–Barr virus before first clinical manifestation of multiple sclerosis

(2012) Bernhard F Décard et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Vitamin D and the anti-viral state

(2011) Jeremy A. Beard et al.   JOURNAL OF CLINICAL VIROLOGY

Effect of vitamin D3 supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

(2011) Stephanie Knippenberg et al.   Multiple Sclerosis Journal

Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy

(2010) Robert Dennert et al.   ANTIVIRAL THERAPY

Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes

(2010) Surya Pavan Yenamandra et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production

(2010) O. Santiago et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis

(2010) Adam E. Handel et al.   PLoS One

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

(2009) Jan D. Lünemann et al.   ANNALS OF NEUROLOGY

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI

(2009) R. A. Farrell et al.   NEUROLOGY

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis

(2008) Samantha Jilek et al.   BRAIN